MENU
+Compare
TELA
Stock ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$1.10
Change
-$0.04 (-3.51%)
Capitalization
45.16M

TELA stock forecast, quote, news & analysis

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy... Show more

TELA
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TELA showed earnings on August 11, 2025. You can read more about the earnings report here.
Interact to see
Advertisement
A.I.Advisor
a Summary for TELA with price predictions
Nov 12, 2025

Momentum Indicator for TELA turns negative, indicating new downward trend

TELA saw its Momentum Indicator move below the 0 level on October 27, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 108 similar instances where the indicator turned negative. In of the 108 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for TELA turned negative on October 29, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TELA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TELA entered a downward trend on November 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for TELA's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TELA advanced for three days, in of 226 cases, the price rose further within the following month. The odds of a continued upward trend are .

TELA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.916) is normal, around the industry mean (63.534). P/E Ratio (0.000) is within average values for comparable stocks, (37.086). TELA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.687). TELA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (0.588) is also within normal values, averaging (79.919).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. TELA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TELA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.76B. The market cap for tickers in the group ranges from 1.86K to 224B. ABT holds the highest valuation in this group at 224B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was 0%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 6%. MOVE experienced the highest price growth at 127%, while MCRXF experienced the biggest fall at -73%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -29%. For the same stocks of the Industry, the average monthly volume growth was -4% and the average quarterly volume growth was 4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 75
Price Growth Rating: 61
SMR Rating: 87
Profit Risk Rating: 93
Seasonality Score: 17 (-100 ... +100)
View a ticker or compare two or three
TELA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a commercial stage medical technology company, which focuses on designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
1 Great Valley Parkway
Phone
+1 484 320-2930
Employees
227
Web
https://www.telabio.com